In celiac disease, the autoantibodies target tissue transglutaminase (TG2), whereas in dermatitis herpetiformis autoantibodies are generated against both TG2 and epidermal transglutaminase (TG3). Here, TGM2 is linked to dermatitis herpetiformis.